Article

Open-Label Placebos for Antidepressant Discontinuation Symptoms: A Series of N-of-1 Trials

2025-09-14

Abstract excerpt

Importance: Antidepressant discontinuation symptoms are highly prevalent and can be severe. Interventions leveraging the placebo effect have the potential to alleviate symptoms and facilitate the discontinuation process. <h4>Objective:</h4> To evaluate the efficacy of open-label placebo (OLP) in reducing antidepressant discontinuation symptoms. Design, Setting, And Participants: A series of randomized, single-blin...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 5cd2541b-972d-543b-901c-ee1a1651f461
DOI: 10.1101/2025.09.12.25335628

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Open-Label Placebos for Antidepressant Discontinuation Symptoms: A Series of N-of-1 TrialsDOI 10.1101/2025.09.12.25335628Read

Trials evaluating drug discontinuation: a scoping review sub-analysis focusing on outcomes and research questionsSemantic proximity Read

Redressing long-term antidepressant use (RELEASE): Pragmatic cluster randomised controlled trial in general practiceSemantic proximity Read

Low predictive power of clinical features for relapse prediction after antidepressant discontinuation in a naturalistic settingSemantic proximity Read

General Characteristics and Reasons for the Discontinuation of Drug Clinical Trials in Mainland ChinaSemantic proximity Read

A Methodological Review of Randomised n-of-1 Trials.Semantic proximity Read

The role of pharmacogenomics in the discontinuation of psychotropic medication: a scoping review protocolSemantic proximity Read

The role of pharmacogenomics in the discontinuation of psychotropic medication: a scoping review protocolSemantic proximity Read

Pharmacological class interventions for benzodiazepine withdrawal discontinuation: a meta-analysisSemantic proximity Read

Machine Learning-Enabled EEG Biomarkers Predict Divergent Antidepressant and Placebo Response in a Clinical Trial of Major DepressionSemantic proximity Read

Prediction of antidepressant side effects in the Genetic Link to Anxiety and Depression StudySemantic proximity Read

Real Life Data for Relugolix/Estradiol/Norethisteroneacetate Treatment for Chronic Pelvic Pain in Endometriosis PatientsSemantic proximity Read

Clinical utility of overviews on adverse events of pharmacological interventionsSemantic proximity Read